title: Measles epidemiology and outbreak response immunization in a rural community in Peru.
abstract: Only limited data are available on the impact of measles outbreak response immunization (ORI) in developing countries. We conducted a community survey in Espindola, a rural border community in northern Peru, following a measles outbreak and subsequent ORI to study the epidemiology and impact of the outbreak and to evaluate the costs and benefits of measles ORI. During the outbreak, 150 of the 553 Espindola residents developed clinical cases of measles. Adults accounted for 44.0% of cases, and were frequently identified as primary cases. The attack rate among all susceptible people was 45.5% and was highest (61.2%) for the 16-20 year age group. Among adults, significant risk factors for developing measles included being aged 16-20 years (relative risk [RR] = 3.06, 95% CI = 2.08, 4.49) and being male (RR = 1.73, 95% CI = 1.11, 2.71). Among serologically confirmed cases, 60.7% developed diarrhoea and 32.1% pneumonia. The overall case-fatality rate was 3.3%, but reached 19.1% in the 0-23-month age group. Failure to reach children through either routine immunization or national campaigns made this community vulnerable to the severe and extensive impact of measles virus importation. The ORI campaign targeted non-measles case children aged 6 months to 15 years, regardless of their previous immunization status, and was effective in terminating this measles outbreak and in preventing morbidity, loss of livelihood and death despite the involvement of large numbers of adults in measles transmission. The last measles case occurred within 3 weeks of completing ORI. The ORI campaign, which would have cost approximately US$ 3000 in 1998, saved as many as 1155 person-days of work among 77 adults, prevented an estimated 87 cases of diarrhoea and 46 cases of pneumonia, and averted 5 deaths.
authors.affiliation: International Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. sniadack@bangla.net
authors.forename: D H
authors.initials: DH
authors.lastname: Sniadack
authors.forename: B
authors.initials: B
authors.lastname: Moscoso
authors.forename: R
authors.initials: R
authors.lastname: Aguilar
authors.forename: J
authors.initials: J
authors.lastname: Heath
authors.forename: W
authors.initials: W
authors.lastname: Bellini
authors.forename: M C
authors.initials: MC
authors.lastname: Chiu
mesh_terms: D000293:Adolescent; D000328:Adult; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D016001:Confidence Intervals; D003362:Cost-Benefit Analysis; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000191:economics; D007223:Infant; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine / Q000191:economics; D010568:Peru / Q000453:epidemiology; D012307:Risk Factors; D012424:Rural Population; D018709:Statistics, Nonparametric
chemical_list: D008458:Measles Vaccine